1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Assay optimization for spatial omics analysis of oropharyngeal cancer tissue
(
- Master (Two yrs)
- 2023
-
Mark
Development of in vitro models that test and predict immune-mediated adverse toxicities
(
- Master (Two yrs)
-
Mark
Mass spectrometry-based proteomic characterization of peripheral immune cells
(
- Master (Two yrs)
-
Mark
The bispecific CD40xEpCAM antibody increase activation in human antigen presenting cell subsets and induce CD8+ T cell proliferation to a greater extent compared to monospecific antibodies
(
- Univ. Diploma
-
Mark
Development and testing of autologous in vitro models for their ability to mimic the immune system’s response toward immunotherapies
(
- Master (Two yrs)
-
Mark
Study of the immunological response from an OMV-based vaccine using ELISA
(
- Master (Two yrs)
- 2022
-
Mark
In vitro assay development and optimization for the prediction of immune-related adverse events following immunotherapy
(
- Master (Two yrs)
-
Mark
In vitro differentiation of human myeloid cell populations.
(
- Master (Two yrs)
- 2021
-
Mark
Validation of a 3D culture model for toxicity studies in malignant and non-cancerous cells
(
- Master (Two yrs)
-
Mark
Optimization of protocol for in vitro generation of HPV-specific T-cell lines
(
- Master (Two yrs)